Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Novartis Ag ADR (NVS)

Novartis Ag ADR (NVS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Novartis Ag ADR LICHTSTRASSE 35 BASEL V8 CH 4056 CHE

P: 41-61-324-1111 F: +41 613247826

Description:

Novartis has one of the strongest and broadest portfolio of oncology drugs and generics. It continues to build depth in 5 core therapeutic areas Cardio-Renal, Immunology, Neuroscience, Oncology and Hematology, strength in technology platforms - Targeted Protein Degradation, Cell Therapy, Gene Therapy, Radioligand Therapy, and xRNA. Novartis efforts to strengthen its wide and deep oncology portfolio by developing breakthrough treatments. Cosentyx, Entresto, Kesimpta, Zolgensma, Kisqali and Leqvio. In March 2015, Novartis acquired certain oncology products and pipeline compounds from Glaxo. In exchange, it sold its non-influenza Vaccines business to Glaxo. Also, the company has spun off the Alcon business into a separate company. In January 2015, Novartis divested its Animal Health division to Lilly. In July 2015, the company divested its influenza vaccines business to CSL Limited. Novartis has also acquired The Medicines Company, adding Leqvio, to its portfolio. Novartis sold its investment in Roche.

Key Statistics

Overview:

Market Capitalization, $K 194,067,168
Enterprise Value, $K 194,935,168
Shares Outstanding, K 2,212,600
Annual Sales, $ 52,877 M
Annual Net Income, $ 24,021 M
Last Quarter Sales, $ 12,842 M
Last Quarter Net Income, $ 1,573 M
60-Month Beta 0.55
% of Insider Shareholders 0.01%
% of Institutional Shareholders 9.14%
Float, K 2,212,379
% Float 99.99%
Short Volume Ratio 0.41

Growth:

1-Year Return 7.08%
3-Year Return -4.97%
5-Year Return 15.88%
5-Year Revenue Growth 6.96%
5-Year Earnings Growth 31.37%
5-Year Dividend Growth 17.51%

Per-Share Information:

Most Recent Earnings 1.58 on 10/25/22
Next Earnings Date N/A
Earnings Per Share ttm 6.00
EPS Growth vs. Prev Qtr 1.28%
EPS Growth vs. Prev Year -7.60%
Annual Dividend Rate, $ 2.16
Annual Dividend Yield 2.46%
Most Recent Dividend 2.161 on 03/08/22
Next Ex-Dividends Date 03/08/22
Dividend Payable Date 03/17/22
Dividend Payout Ratio 36.14%
Most Recent Split 108-95 on 04/09/19

NVS Ratios

Ratio
Price/Earnings ttm 14.55
Price/Earnings forward 14.52
Price/Earnings to Growth 2.53
Return-on-Equity % 20.89%
Return-on-Assets % 10.62%
Profit Margin % 45.43
Net Margin % 18.05
Debt/Equity 0.35
Price/Sales 3.74
Price/Cash Flow 9.68
Price/Book 3.17
Book Value/Share 27.52
Interest Coverage 33.23

NVS Dividends

Date Value
03/08/22 $2.1610
03/04/21 $2.0790
03/03/20 $2.0070
03/04/19 $1.8420
03/06/18 $2.9770
03/01/17 $2.3270
02/24/16 $2.3400
03/02/15 $2.8169
02/27/14 $2.7186
02/26/13 $2.5300
02/27/12 $2.4601
02/24/11 $2.3527
03/02/10 $1.9866
02/24/09 $1.7201
02/26/08 $1.4719
03/06/07 $1.0813
02/28/06 $0.8942
03/01/05 $0.8635
02/24/04 $0.8061
03/04/03 $0.6999
03/21/02 $0.5220
03/22/01 $0.5015
11/14/00 $1.0780
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar